Literature DB >> 18538534

Why do revision knee arthroplasties fail?

Juan Suarez1, William Griffin, Bryan Springer, Thomas Fehring, J Bohannon Mason, Susan Odum.   

Abstract

This study identified the mechanisms of failure and the variables associated with failure after revision knee arthroplasty. Five hundred sixty-six index revision knee arthroplasties were studied. Of index revisions, 12.0% failed at an average of 40.1 months. Predominant revision failure modes included infection (46%), aseptic loosening (19%), and instability (13%). Only 4.3% of knees revised for aseptic loosening required rerevision as compared to 21% of knees revised for infection. Revision knee arthroplasty was more likely to fail in younger patients and in those who underwent polyethylene exchanges. Mechanisms of failure for revision arthroplasties are different than for primary knee arthroplasties. Revisions for infection are 4 times more likely to fail than revisions for aseptic loosening. The survivorship for the entire cohort, with revision for any reason as an end point, was 82% at 12 years.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538534     DOI: 10.1016/j.arth.2008.04.020

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  30 in total

1.  The adductor tubercle: an important landmark to determine the joint line level in revision total knee arthroplasty.

Authors:  Francesco Iacono; Giovanni Francesco Raspugli; Giuseppe Filardo; Danilo Bruni; Stefano Zaffagnini; Simone Bignozzi; Mirco Lo Presti; Ibrahim Akkawi; Maria Pia Neri; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-03-12       Impact factor: 4.342

2.  Cementless revision TKA with bone grafting of osseous defects restores bone stock with a low revision rate at 4 to 10 years.

Authors:  S A Hanna; W J S Aston; N J de Roeck; A Gough-Palmer; D P Powles
Journal:  Clin Orthop Relat Res       Date:  2011-06-16       Impact factor: 4.176

3.  Predictive factors for failure after total knee replacement revision.

Authors:  Rafael Luque; Belen Rizo; Antonio Urda; Rodrigo Garcia-Crespo; Enrique Moro; Fernando Marco; Luis López-Duran
Journal:  Int Orthop       Date:  2014-01-09       Impact factor: 3.075

4.  Infection and periprosthetic fracture are the leading causes of failure after aseptic revision total knee arthroplasty.

Authors:  Juliette A Meyer; Mark Zhu; Alana Cavadino; Brendan Coleman; Jacob T Munro; Simon W Young
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-30       Impact factor: 3.067

5.  Predisposing factors which are relevant for the clinical outcome after revision total knee arthroplasty.

Authors:  Francois Hardeman; Jürgen Londers; Alexander Favril; Erik Witvrouw; Johan Bellemans; Jan Victor
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-07-29       Impact factor: 4.342

6.  Primary modular total knee replacement in severe and unstable osteoarthritis. Predictive factors for failure.

Authors:  Rafael Luque; Belen Rizo; Antonio Urda; Rodrigo Garcia-Crespo; Enrique Moro; Luis López-Durán
Journal:  Int Orthop       Date:  2015-07-01       Impact factor: 3.075

7.  Polyethylene quality affects revision knee liner exchange survivorship.

Authors:  C Anderson Engh; Nancy L Parks; Gerard A Engh
Journal:  Clin Orthop Relat Res       Date:  2012-01       Impact factor: 4.176

8.  Revision total knee arthroplasty infection: incidence and predictors.

Authors:  S M Javad Mortazavi; Justin Schwartzenberger; Matthew S Austin; James J Purtill; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

9.  Risk of subsequent revision after primary and revision total joint arthroplasty.

Authors:  Kevin L Ong; Edmund Lau; Jeremy Suggs; Steven M Kurtz; Michael T Manley
Journal:  Clin Orthop Relat Res       Date:  2010-05-25       Impact factor: 4.176

10.  Midterm assessment of causes and results of revision total knee arthroplasty.

Authors:  Fahad Hossain; Shelain Patel; Fares Sami Haddad
Journal:  Clin Orthop Relat Res       Date:  2010-05       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.